This Article Full Text Full Text (PDF) All Versions of this Article: 146/6/2501    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pazirandeh, A. Articles by Okret, S. Search for Related Content PubMed PubMed Citation Articles by Pazirandeh, A. Articles by Okret, S.

Conditional Expression of a Glucocorticoid Receptor Transgene in Thymocytes Reveals a Role for Thymic-Derived Glucocorticoids in Thymopoiesis in Vivo

Department of Medical Nutrition (A.P., S.O.), Karolinska Institutet, Karolinska University Hospital Huddinge, Novum, SE-141 86 Huddinge, Sweden; and Microbiology and Tumour Biology Center (M.J.), Karolinska Institutet, SE-171 77 Stockholm, Sweden

Address all correspondence and requests for reprints to: Prof. Sam Okret, Department of Medical Nutrition, Karolinska Institutet, Karolinska University Hospital Huddinge, Novum, SE-141 86 Huddinge, Sweden. E-mail: Sam.Okret{at}mednut.ki.se.

We and others have previously reported that thymic epithelial cells produce glucocorticoids (GCs). In vitro studies have also suggested that thymic-derived GCs play a role in the development of thymocytes. However, until now it has not yet been established whether thymic-derived GCs play a role in thymopoiesis in vivo. To investigate this, we conditionally overexpressed the GC receptor (GR) in thymocytes using transgenic mice with a tetracycline-inducible expression system. The influence of systemic GCs was excluded by adrenalectomizing the transgenic mice before the GR induction. Conditional expression of transgenic GR in the thymocytes of adrenalectomized transgenic mice led to a decrease in the thymocyte number. This was associated with increased thymocyte apoptosis. The effect of thymic-derived GCs on the thymocytes was confirmed after transgenic GR induction in a thymic organ culture system. Finally, the GR antagonist RU486 increased thymocyte number in adrenalectomized mice in vivo and prevented a reduction in thymocyte number in thymic organ culture after transgenic GR induction. These observations further confirmed a role for the thymic-derived GCs in regulating thymocyte homeostasis in vivo.

This article has been cited by other articles:

				K. L. Schmidt and K. K. Soma Cortisol and corticosterone in the songbird immune and nervous systems: local vs. systemic levels during development Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R103 - R110. [Abstract] [Full Text] [PDF]

				J. v. d. Brandt, F. Luhder, K. G. McPherson, K. L. de Graaf, D. Tischner, S. Wiehr, T. Herrmann, R. Weissert, R. Gold, and H. M. Reichardt Enhanced Glucocorticoid Receptor Signaling in T Cells Impacts Thymocyte Apoptosis and Adaptive Immune Responses Am. J. Pathol., March 1, 2007; 170(3): 1041 - 1053. [Abstract] [Full Text] [PDF]

				T. J. Cole, D. R. Liddicoat, and D. I. Godfrey Intrathymic Glucocorticoid Production and Thymocyte Survival: Another Piece in the Puzzle Endocrinology, June 1, 2005; 146(6): 2499 - 2500. [Full Text] [PDF]